These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1039 related items for PubMed ID: 17186555

  • 1. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
    Xu ZP, Kurniawan ND, Bartlett PF, Lu GQ.
    Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M, Selegård L, Klasson A, Söderlind F, Abrikossova N, Skoglund C, Bengtsson T, Engström M, Käll PO, Uvdal K.
    Langmuir; 2010 Apr 20; 26(8):5753-62. PubMed ID: 20334417
    [Abstract] [Full Text] [Related]

  • 3. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
    Laus S, Ruloff R, Tóth E, Merbach AE.
    Chemistry; 2003 Aug 04; 9(15):3555-66. PubMed ID: 12898682
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
    Livramento JB, Helm L, Sour A, O'Neil C, Merbach AE, Tóth E.
    Dalton Trans; 2008 Mar 07; (9):1195-202. PubMed ID: 18283380
    [Abstract] [Full Text] [Related]

  • 6. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
    Rowe MD, Chang CC, Thamm DH, Kraft SL, Harmon JF, Vogt AP, Sumerlin BS, Boyes SG.
    Langmuir; 2009 Aug 18; 25(16):9487-99. PubMed ID: 19422256
    [Abstract] [Full Text] [Related]

  • 7. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z, Yu D, Liu C, Yang X, Zhang N, Ma C, Song J, Lu Z.
    J Drug Target; 2011 Sep 18; 19(8):657-65. PubMed ID: 21091273
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel cholic acid-based contrast enhancement agent for targeted MRI.
    Chong HS, Song HA, Lim S, Macrenaris K, Ma X, Lee H, Bui P, Meade T.
    Bioorg Med Chem Lett; 2008 Apr 01; 18(7):2505-8. PubMed ID: 18337094
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
    Park JY, Baek MJ, Choi ES, Woo S, Kim JH, Kim TJ, Jung JC, Chae KS, Chang Y, Lee GH.
    ACS Nano; 2009 Nov 24; 3(11):3663-9. PubMed ID: 19835389
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A chemical strategy for the relaxivity enhancement of Gd(III) chelates anchored on mesoporous silica nanoparticles.
    Carniato F, Tei L, Cossi M, Marchese L, Botta M.
    Chemistry; 2010 Sep 17; 16(35):10727-34. PubMed ID: 20669190
    [Abstract] [Full Text] [Related]

  • 14. [Synthesis, characterization and relaxivity of dimeric DTPA-gadonium (III) complexes with long chain alkyl esters of L-lysine].
    Yu KC, Liu LY, Wan FX, Zhou JL, Ding SW, Ye CH.
    Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Apr 17; 26(4):670-3. PubMed ID: 16836136
    [Abstract] [Full Text] [Related]

  • 15. Gd(III) complexes intercalated into hydroxy double salts as potential MRI contrast agents.
    Jin M, Spillane DE, Geraldes CF, Williams GR, Bligh SW.
    Dalton Trans; 2015 Dec 21; 44(47):20728-34. PubMed ID: 26568157
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imaging and emission spectroscopy.
    Haar PJ, Broaddus WC, Chen ZJ, Fatouros PP, Gillies GT, Corwin FD.
    Phys Med Biol; 2010 Jun 21; 55(12):3451-65. PubMed ID: 20508321
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S, Torres S, Martins AF, Martins JA, André JP, Helm L, Prata MI, Santos AC, Geraldes CF.
    Dalton Trans; 2009 Jun 28; (24):4656-70. PubMed ID: 19513474
    [Abstract] [Full Text] [Related]

  • 20. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
    Xu J, Churchill DG, Botta M, Raymond KN.
    Inorg Chem; 2004 Sep 06; 43(18):5492-4. PubMed ID: 15332797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.